Publications
Showing 261 to 270 of 560 Publications
| Title | Authors | Year | Journal |
|---|---|---|---|
| Using Twitter to Examine Stigma Against People with Dementia During COVID-19: Infodemiology Study | Bacsu, J. D.**, Fraser, S.*, Chasteen, A. L.*, Cammer, A.*, Grewal, K. S.**, Bechard, L. E.**, Bethell, J.*, Green, S., McGilton, K. S.*, Morgan, D.*, O'Rourke, H. M.*, Poole, L., Spiteri, R. J., & O'Connell, M. E.* | 2022 | JMIR Aging |
| Dual-task gait and incident dementia-A step forward, but not there yet-reply | Montero-Odasso, M., Camicioli, R., & Muir-Hunter, S.W. | 2017 | JAMA Neurology |
| White matter degeneration – a treatable target? | Roseborough A**, Hachinski V*, Whitehead S* | 2020 | JAMA Neurology |
| Association of dual-task gait with incident dementia in mild cognitive impairment: Results from the Gait and Brain Study | Montero-Odasso, M. M., Sarquis-Adamson, Y., Speechley, M., Borrie, M. J., Hachinski, V. C., Wells, J., Riccio, P. M., Schapira, M., Sejdic, E., Camicioli, R., Bartha, R., McIlroy, W. E., & Muir-Hunter, S. | 2017 | JAMA Neurology |
| Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β | Therriault J, Benedet AL, Pascoal TA, Mathotaarachchi S, Chamoun M, Savard M, Thomas E, Kang MS, Lussier F, Tissot C, Parsons M, Qureshi MNI, Vitali P, Massarweh G, Soucy JP, Rej S, Saha-Chaudhuri P, Gauthier S*, Rosa-Neto P* | 2019 | JAMA Neurology |
| Frequency of loss of function variants in LRRK2 in Parkinson Disease | Blauwendraat, C., Reed, X., Kia, D.A., Gan-Or, Z., Lesage, S., Pihlstrom, L., Guerreiro, R., Gibbs, J.R., Sabir M., Ahmed, S., Ding, J., Alcalay, R.N., Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease. Hassin-Baer, S., Pittma,n A.M., Brooks, J., Edsall, C., Hernandez, D.G., Chung, S.J., Goldwurm, S., Toft, M., Schulte, C., Bras, J., Wood, N.W., Brice, A., Morris, H.R., Scholz, S.W., Nalls, M.A., Singleton, A.B., Cookson, M.R., for the COURAGE-PD Consortium, the French Parkinson's Disease Consortium, & the International Parkinson's Disease Genomics Consortium. | 2018 | JAMA Neurology |
| Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum | Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier FZ, Karikari TK, Hourregue C, Cognat E, Dumurgier J, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Salvadó G, Shekari M, Operto G, Gispert JD, Minguillon C, Fauria K, Kollmorgen G, Suridjan I, Zimmer ER, Zetterberg H, Molinuevo JL, Paquet C, Rosa-Neto P*, Blennow K, Suárez-Calvet M, for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer’s and Families (ALFA) study, and BioCogBank Paris Lariboisière cohort | 2021 | JAMA Neurology |
| Alzheimer Disease, biomarkers, and clinical symptoms – Quo Vadis? | Montero-Odasso M*, Ismail Z*, Camicioli R* | 2020 | JAMA Neurology |
| Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment | Manuel M. Montero-Odasso, Yanina Sarquis-Adamson, Mark Speechley, Michael J. Borrie, Vladimir C. Hachinski, Jennie Wells, Patricia M. Riccio, Marcelo Schapira, Ervin Sejdic, Richard M. Camicioli, Robert Bartha, William E. McIlroy, Susan Muir-Hunter | JAMA Neurology | |
| Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment: A Randomized Clinical Trial | Montero-Odasso, M.*, Zou, G.*, Speechley, M.*, Almeida, Q. J.*, Liu-Ambrose, T.*, Middleton, L. E.*, Camicioli, R.*, Bray, N. W.**, Li, K. Z. H.*, Fraser, S.*, Pieruccini-Faria, F.**, Berryman, N., Lussier, M.**, Shoemaker, J. K.*, Son, S.**, Bherer, L.*, & Canadian Gait and Cognition Network | 2023 | JAMA Network Open |
Showing 261 to 270 of 560 Publications